Insider · CIK 0001761167

Cawkwell Gail

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001761167

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-01	ACRSAclaris Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+15K sh	—	—	15,000
2023-07-01	ACRSAclaris Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−5,407 sh	$10.37	−$56.1K	9,593
2023-07-01	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−15K sh	—	—	45,000
2023-02-01	ACRSAclaris Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+105K sh	—	—	105,000
2023-02-01	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2022-07-01	ACRSAclaris Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+210K sh	—	—	210,000
2022-07-01	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2022-02-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−320 sh	$15.80	−$5,056	35,740
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	SVP, Med Affairs, Safety & PV	AAward	+6,600 sh	—	—	36,060
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	SVP, Med Affairs, Safety & PV	AAward	+11.3K sh	—	—	11,300
2021-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−2,455 sh	$16.29	−$40K	29,460
2021-11-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$19.04	−$6,073.76	31,915
2021-08-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$15.28	−$4,874.32	32,234
2021-05-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$17.75	−$5,662.25	32,553
2021-02-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$31.32	−$9,991.08	32,872
2021-01-22	INTERCEPT PHARMACEUTICALS, INC.A Award	SVP, Med Affairs, Safety & PV	AAward	+12.6K sh	—	—	33,191
2021-01-22	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	SVP, Med Affairs, Safety & PV	AAward	+19.7K sh	—	—	19,700
2020-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−706 sh	$24.70	−$17.4K	20,591
2020-11-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$38.52	−$12.3K	21,297
2020-08-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$53.44	−$17K	21,616
2020-05-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$89.05	−$28.4K	21,935
2020-02-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$96.74	−$30.9K	22,254
2020-01-23	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	SVP, Med Affairs, Safety & PV	AAward	+6,900 sh	—	—	6,900
2020-01-23	INTERCEPT PHARMACEUTICALS, INC.A Award	SVP, Med Affairs, Safety & PV	AAward	+4,200 sh	—	—	22,573
2019-12-31	INTERCEPT PHARMACEUTICALS, INC.S Sale	SVP, Med Affairs, Safety & PV	SSale	−262 sh	$125.00	−$32.8K	18,722
2019-12-31	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	+262 sh	$54.63	+$14.3K	18,984
2019-12-31	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	−262 sh	—	—	20,779
2019-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−349 sh	$123.92	−$43.2K	18,373
2019-12-26	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	+54 sh	$54.63	+$2,950.02	18,776
2019-12-26	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	−54 sh	—	—	21,041
2019-12-26	INTERCEPT PHARMACEUTICALS, INC.S Sale	SVP, Med Affairs, Safety & PV	SSale	−54 sh	$125.00	−$6,750	18,722
2019-12-03	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	−80 sh	—	—	21,095
2019-12-03	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	+80 sh	$54.63	+$4,370.4	18,722
2019-11-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$83.02	−$26.5K	18,642
2019-08-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$65.89	−$21K	18,961
2019-05-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−319 sh	$86.66	−$27.6K	19,280
2019-04-18	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	−1,750 sh	—	—	21,175
2019-04-18	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	SVP, Med Affairs, Safety & PV	MExercise/Conversion	+1,750 sh	$54.63	+$95.6K	19,599
2019-02-12	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	SVP, Med Affairs, Safety & PV	FTax Payment	−1,276 sh	$111.05	−$142K	17,849
2019-01-16	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	SVP, Med Affairs, Safety & PV	AAward	+6,700 sh	—	—	6,700
2019-01-16	INTERCEPT PHARMACEUTICALS, INC.A Award	SVP, Med Affairs, Safety & PV	AAward	+4,100 sh	—	—	19,125

Recent filings

Accepted (ET)
Jul 54
Cawkwell Gail0001209191-23-041060
SEC(opens sec.gov)
Feb 34
Cawkwell Gail0001209191-23-006982
SEC(opens sec.gov)
Jul 54
Cawkwell Gail0001209191-22-040787
SEC(opens sec.gov)
Feb 154
Cawkwell Gail0001104659-22-023838
SEC(opens sec.gov)
Jan 314
Cawkwell Gail0001104659-22-009553
SEC(opens sec.gov)
Jan 44
Cawkwell Gail0001104659-22-000909
SEC(opens sec.gov)
Nov 164
Cawkwell Gail0001104659-21-140028
SEC(opens sec.gov)
Aug 134
Cawkwell Gail0001104659-21-105301
SEC(opens sec.gov)
May 134
Cawkwell Gail0001104659-21-066143
SEC(opens sec.gov)
Feb 174
Cawkwell Gail0001104659-21-024922
SEC(opens sec.gov)
Jan 264
Cawkwell Gail0001104659-21-007776
SEC(opens sec.gov)
Jan 54
Cawkwell Gail0001104659-21-001115
SEC(opens sec.gov)
Nov 164
Cawkwell Gail0001104659-20-125980
SEC(opens sec.gov)
Aug 144
Cawkwell Gail0001104659-20-095692
SEC(opens sec.gov)

Companies

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37

NEW YORK, NY, 10001